R&D CAMP4 on a new class of ASO in gene under expression CAMP4 Therapeutics CFO Kelly Gold discusses developments in antisense oligonucleotides and CAMP4’s CMP-002 study
R&D Sponsored The future of cardiometabolic trials: From obesity to outcom... Gain practical insight into how leading experts are designing the next generation of cardiometabolic trials in an upcoming webinar from hVIVO
R&D Sponsored Solving for industry-wide clinical trial development challen... PurpleLab Managed Services empower clinical development teams to reduce risks and optimise trial execution.
Digital Initial leap of faith inspires today’s fast-growing digital ... Explore how Tufts Center for the Study of Drug Development has spearheaded the growth of digital clinical trials through an initial leap of faith
News TransThera's resistant biliary cancer drug cleared in China TransThera's Yochanra has been cleared in China as the world's first drug that can overcome resistance to FGFR inhibitors in cholangiocarcinoma.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
